It is not that substance abuse treatment has made no advances - instead, the problem is that these advances have not translated into the treatment system at the community level. This """"""""disconnect"""""""" (Leshner) or """"""""gap"""""""" (the Institute of Medicine) prompted the recommendation that NIDA establish a mechanism to facilitate transfer of research findings into the community. The proposed Clincial Trial Network (CTN) is the result of that recommendation. As envisioned, the proposed UCLA CTN Node will conduct and participate in behavioral, pharmacological, and combined behavioral and pharmacological treatment trials for drug abuse dependence and will conduct research on treatment practices within and across CTN Nodes. The UCLA Node would effectively bring together an outstanding group of investigators and a diverse array of community treatment programs with the expertise to respond to the envisioned needs of the CTN. The group has a track record for organizing and conducting multi-center studies and a successful history of working collaboratively with NIDA and other investigators across the nation on the one hand, and with community groups on the other. This proposal outlines an existing clinical infrastructure, which encompasses a system of community-based treatment clinics in Southern California, and describes a further partnership with four other community-based clinics, each with unique contributions for the CTN. The proposal details the training and research experience of the proposed group and the established training and research infrastructure that can be expanded to accommodate the needs of the Network. The proposal outlines an administrative infrastructure that the group has used successfully for the past several decades and which can be enhanced to meet CTN requirements. Finally, the proposal presents three research concepts for the Steering Committee's consideration. These concepts exemplify the group's experience and current thinking about projects that would be suitable for study within the CTN.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
3U10DA013045-04S1
Application #
6664836
Study Section
Special Emphasis Panel (ZDA1 (12))
Program Officer
Tai, Betty
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
4
Fiscal Year
2002
Total Cost
$300,000
Indirect Cost
Name
University of California Los Angeles
Department
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Tomko, Rachel L; Baker, Nathaniel L; McClure, Erin A et al. (2018) Incremental validity of estimated cannabis grams as a predictor of problems and cannabinoid biomarkers: Evidence from a clinical trial. Drug Alcohol Depend 182:1-7
Levran, Orna; Correa da Rosa, Joel; Randesi, Matthew et al. (2018) A non-coding CRHR2 SNP rs255105, a cis-eQTL for a downstream lincRNA AC005154.6, is associated with heroin addiction. PLoS One 13:e0199951
Zhu, Yuhui; Evans, Elizabeth A; Mooney, Larissa J et al. (2018) Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial. J Neuroimmune Pharmacol 13:488-497
Crist, R C; Doyle, G A; Nelson, E C et al. (2018) A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence. Pharmacogenomics J 18:173-179
Crist, Richard C; Li, James; Doyle, Glenn A et al. (2018) Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate. Am J Drug Alcohol Abuse 44:431-440
Winhusen, Theresa; Feaster, Daniel J; Duan, Rui et al. (2018) Baseline Cigarette Smoking Status as a Predictor of Virologic Suppression and CD4 Cell Count During One-Year Follow-Up in Substance Users with Uncontrolled HIV Infection. AIDS Behav 22:2026-2032
McCollister, Kathryn E; Leff, Jared A; Yang, Xuan et al. (2018) Cost of pharmacotherapy for opioid use disorders following inpatient detoxification. Am J Manag Care 24:526-531
Garrett, Sharon B; Doyle, Suzanne R; Peavy, K Michelle et al. (2018) Age differences in outcomes among patients in the ""Stimulant Abuser Groups to Engage in 12-Step"" (STAGE-12) intervention. J Subst Abuse Treat 84:21-29
Lévesque, Annie; Campbell, Aimee N C; Pavlicova, Martina et al. (2017) Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial. Addict Behav 65:74-80
Hser, Yih-Ing; Huang, David; Saxon, Andrew J et al. (2017) Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine?+?Naloxone and Methadone. J Addict Med 11:63-69

Showing the most recent 10 out of 112 publications